Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Bile duct ligation in neonatal rats: is it a valid experimental model for biliary atresia studies?

Gibelli NE, Tannuri U, de Mello ES, Rodrigues CJ.

Pediatr Transplant. 2009 Feb;13(1):81-7. doi: 10.1111/j.1399-3046.2008.00947.x.

PMID:
18452497
2.

Immunohistochemical studies of stellate cells in experimental cholestasis in newborn and adult rats.

Gibelli NE, Tannuri U, Mello ES.

Clinics (Sao Paulo). 2008 Oct;63(5):689-94.

3.

Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction-an experimental study in growing animals.

Andrade Wde C, Tannuri U, da Silva LF, Alves VA.

J Pediatr Surg. 2009 Nov;44(11):2071-7. doi: 10.1016/j.jpedsurg.2009.05.020.

PMID:
19944210
4.

Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model.

Sant'Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O.

Cell Transplant. 2011;20(3):441-53. doi: 10.3727/096368910X522252.

PMID:
20719087
5.

Halofuginone can worsen liver fibrosis in bile duct obstructed rats.

Van de Casteele M, Roskams T, Van der Elst I, van Pelt JF, Fevery J, Nevens F.

Liver Int. 2004 Oct;24(5):502-9.

PMID:
15482349
6.

Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.

Türkçapar N, Bayar S, Koyuncu A, Ceyhan K.

Hepatogastroenterology. 2003 May-Jun;50(51):680-3.

PMID:
12828059
7.

[Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat].

Marinelli Ibarreta A, Sánchez Movilla A, Izquierdo F, Burgos Lázaro F, Arce Alvarez A, del Castillo-Olivares Ramos JL.

Rev Esp Enferm Dig. 1995 Jan;87(1):25-31. Spanish.

PMID:
7727164
8.

T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model.

Wang YX, Yuan J, Chu ES, Go MY, Huang H, Ahuja AT, Sung JJ, Yu J.

Radiology. 2011 Jun;259(3):712-9. doi: 10.1148/radiol.11101638.

PMID:
21436087
9.

Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats.

Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Franchitto A, Onori P, Ueno Y, Marzioni M, Fava G, Venter J, Reichenbach R, Summers R, Alpini G.

Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G307-17.

10.

Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.

Jover R, Rodrigo R, Felipo V, Insausti R, Sáez-Valero J, García-Ayllón MS, Suárez I, Candela A, Compañ A, Esteban A, Cauli O, Ausó E, Rodríguez E, Gutiérrez A, Girona E, Erceg S, Berbel P, Pérez-Mateo M.

Hepatology. 2006 Jun;43(6):1257-66. Erratum in: Hepatology. 2006 Sep;44(3):771.

PMID:
16729306
11.

Cell proliferation activity of proliferating bile duct after bile duct ligation in rats.

Yoshioka K, Mori A, Taniguchi K, Mutoh K.

Vet Pathol. 2005 May;42(3):382-5.

12.

Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver.

Kloek JJ, Marsman HA, van Vliet AK, Gouma DJ, van Gulik TM.

Surgery. 2008 Jul;144(1):22-31. doi: 10.1016/j.surg.2008.03.030.

PMID:
18571581
13.

Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.

Ramalho LN, Ramalho FS, Zucoloto S, Castro-e-Silva Júnior O, Corrêa FM, Elias Júnior J, Magalhães JF.

Hepatogastroenterology. 2002 Nov-Dec;49(48):1499-502.

PMID:
12397717
14.
15.

Biliary hypertension as the cell proliferation trigger in bile duct ligated rats.

Azmaiparashvili E, Kordzaia D, Dzidziguri D.

Georgian Med News. 2009 Mar;(168):111-6.

PMID:
19359736
16.

Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats.

Karaman A, Demirbilek S, Sezgin N, Gürbüz N, Gürses I.

J Pediatr Surg. 2003 Sep;38(9):1341-7.

PMID:
14523817
17.

Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats.

Aksu B, Umit H, Kanter M, Guzel A, Inan M, Civelek S, Aktas C, Uzun H.

J Pediatr Surg. 2009 Apr;44(4):702-10. doi: 10.1016/j.jpedsurg.2008.09.016.

PMID:
19361629
18.

Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, Kolb A, Friess H, Schuppan D.

J Hepatol. 2008 Mar;48(3):453-64. doi: 10.1016/j.jhep.2007.11.021.

PMID:
18221819
19.

Lack of detrimental or therapeutic effects of cyclooxygenase inhibition in bile duct-ligated rats with hepatic encephalopathy.

Chan CY, Lee FY, Wang TF, Huang SW, Chang FY, Lu RH, Chen YC, Wang SS, Huang HC, Lee SD.

J Gastroenterol Hepatol. 2006 Sep;21(9):1483-7.

PMID:
16911697
20.

[Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].

Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han KH.

Korean J Hepatol. 2008 Jun;14(2):159-67. doi: 10.3350/kjhep.2008.14.2.159. Korean.

Items per page

Supplemental Content

Support Center